Amyloid P Component Promotes Aggregation of Alzheimer′s β-Amyloid Peptide

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemical and Biophysical Research Communications

• Publication date

  1995-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1995.1819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis

  2025cites this paper
• Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders

  2024cites this paper
• Serum amyloid P component accumulates and persists in neurones following traumatic brain injury

  2023cites this paper
• Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature

  2023cites this paper
• Dementia in the older population is associated with neocortex content of serum amyloid P component

  2021cites this paper
• Biological and methodological complexities of beta‐amyloid peptide: Implications for Alzheimer’s disease research

  2021cites this paper
• Dementia in the older population is associated with neocortex content of serum amyloid P component

  2021cites this paper
• Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme

  2020cites this paper
• Blood-based protein mediators of senility with replications across biofluids and cohorts

  2019cites this paper
• The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs

  2018cites this paper
• Amyloid-β and lysozyme proteotoxicity in Drosophila : Beneficial effects of lysozyme and serum amyloid P component in models of Alzheimer’s disease and lysozyme amyloidosis

  2017influential citation
• Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo

  2016cites this paper
• Understanding the dual nature of lysozyme: part villain – part hero : A Drosophila melanogaster model of lysozyme amyloidosis

  2014cites this paper
• Inhibition of TTR Aggregation-Induced Cell Death – A New Role for Serum Amyloid P Component

  2013cites this paper
• Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide

  2013cites this paper
• Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease

  2012cites this paper
• Pentraxins and Alzheimer's disease: at the interface between biomarkers and pharmacological targets.

  2012cites this paper
• Anti‐Misfolding and Anti‐Fibrillization Therapies for Protein Misfolding Disorders

  2010cites this paper
• Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

  2009cites this paper
• Therapeutic strategies against protein misfolding in neurodegenerative diseases

  2009cites this paper
• Extracellular Chaperones and Amyloids

  2008influential citation
• Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.

  2008cites this paper
• Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

  2008cites this paper
• Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment

  2007cites this paper
• Design of Inhibitors of Amyloid-β Misfolding and Aggregation for Alzheimer's Therapy

  2007cites this paper
• New Molecular Histopathologic Insights Into the Pathogenesis of Age-related Macular Degeneration

  2007cites this paper
• Protein misfolding disorders and rational design of antimisfolding agents.

  2006cites this paper
• High density lipoproteins bind Abeta and apolipoprotein C-II amyloid fibrils.

  2006cites this paper
• The influence of phospholipid membranes on bovine calcitonin peptide's secondary structure and induced neurotoxic effects.

  2005cites this paper
• Studies of serum amyloid P component (SAP) and antinuclear autoimmunity

  2004cites this paper
• Serum amyloid P component induces neuronal apoptosis and beta-amyloid immunoreactivity.

  2003cites this paper
• Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.

  2003cites this paper
• The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

  2002cites this paper
• The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases.

  2001cites this paper
• Inflammation and Alzheimer's disease.

  2000cites this paper
• INFLAMMATION AND ALZHEIMERS DISEASE

  2000cites this paper
• Assessment of cerebrospinal fluid levels of serum amyloid P component in patients with Alzheimer's disease.

  1999cites this paper
• Inflammatory Mechanisms of Alzheimer’s Disease

  1998cites this paper
• Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein.

  1998cites this paper
• Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.

  1998cites this paper
• Amyloid β-Peptide-induced Inhibition of MTT Reduction in PC12h and C1300 Neuroblastoma Cells: Effect of Nitroprusside

  1998cites this paper
• Protein aggregation: folding aggregates, inclusion bodies and amyloid.

  1998cites this paper
• The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions.

  1998cites this paper
• Amyloid P component. A critical review

  1997cites this paper
• Inflammatory Mediators in Alzheimer’s Disease

  1997cites this paper
• The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.

  1996cites this paper
• Inflammation and Alzheimer's disease pathogenesis.

  1996cites this paper
• Studies on amyloid formation in familial amyloidotic polyneuropathy

  1996cites this paper